AviadoBio
AviadoBio is a biopharmaceutical development company focused on developing medicines for patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company uses gene therapy platforms and delivery technologies to address medical needs in neurodegenerative diseases.
- Gene therapy for FTD and ALS
- Precision drug delivery systems
- Clinical trials for neurodegenerative diseases